Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial.
Identifieur interne : 003B52 ( PubMed/Checkpoint ); précédent : 003B51; suivant : 003B53Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial.
Auteurs : Kate Keenan [États-Unis] ; Alison E. Hipwell ; Jenna Bortner ; Amy Hoffmann ; Rose McaloonSource :
- Obstetrics and gynecology [ 1873-233X ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- métabolisme : Stress psychologique.
- psychologie : Afro-Américains, Grossesse.
- sang : Grossesse, Hydrocortisone, Stress psychologique.
- usage thérapeutique : Acides gras omega-3.
- Adulte, Compléments alimentaires, Femelle, Humains, Jeune adulte, Prise en charge prénatale.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Hydrocortisone.
- chemical , therapeutic use : Fatty Acids, Omega-3.
- blood : Pregnancy, Stress, Psychological.
- metabolism : Stress, Psychological.
- psychology : African Americans, Pregnancy.
- Adult, Dietary Supplements, Female, Humans, Prenatal Care, Young Adult.
Abstract
To test the association between docosahexaenoic acid (DHA) supplementation and perceived stress and cortisol response to a stressor during pregnancy in a sample of African American women living in low-income environments.
DOI: 10.1097/AOG.0000000000000559
PubMed: 25415158
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25415158Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial.</title>
<author><name sortKey="Keenan, Kate" sort="Keenan, Kate" uniqKey="Keenan K" first="Kate" last="Keenan">Kate Keenan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois; and the Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois; and the Department of Psychiatry, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hipwell, Alison E" sort="Hipwell, Alison E" uniqKey="Hipwell A" first="Alison E" last="Hipwell">Alison E. Hipwell</name>
</author>
<author><name sortKey="Bortner, Jenna" sort="Bortner, Jenna" uniqKey="Bortner J" first="Jenna" last="Bortner">Jenna Bortner</name>
</author>
<author><name sortKey="Hoffmann, Amy" sort="Hoffmann, Amy" uniqKey="Hoffmann A" first="Amy" last="Hoffmann">Amy Hoffmann</name>
</author>
<author><name sortKey="Mcaloon, Rose" sort="Mcaloon, Rose" uniqKey="Mcaloon R" first="Rose" last="Mcaloon">Rose Mcaloon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25415158</idno>
<idno type="pmid">25415158</idno>
<idno type="doi">10.1097/AOG.0000000000000559</idno>
<idno type="wicri:Area/PubMed/Corpus">000E41</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E41</idno>
<idno type="wicri:Area/PubMed/Curation">000E38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E38</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000E38</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial.</title>
<author><name sortKey="Keenan, Kate" sort="Keenan, Kate" uniqKey="Keenan K" first="Kate" last="Keenan">Kate Keenan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois; and the Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois; and the Department of Psychiatry, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hipwell, Alison E" sort="Hipwell, Alison E" uniqKey="Hipwell A" first="Alison E" last="Hipwell">Alison E. Hipwell</name>
</author>
<author><name sortKey="Bortner, Jenna" sort="Bortner, Jenna" uniqKey="Bortner J" first="Jenna" last="Bortner">Jenna Bortner</name>
</author>
<author><name sortKey="Hoffmann, Amy" sort="Hoffmann, Amy" uniqKey="Hoffmann A" first="Amy" last="Hoffmann">Amy Hoffmann</name>
</author>
<author><name sortKey="Mcaloon, Rose" sort="Mcaloon, Rose" uniqKey="Mcaloon R" first="Rose" last="Mcaloon">Rose Mcaloon</name>
</author>
</analytic>
<series><title level="j">Obstetrics and gynecology</title>
<idno type="eISSN">1873-233X</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>African Americans (psychology)</term>
<term>Dietary Supplements</term>
<term>Fatty Acids, Omega-3 (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrocortisone (blood)</term>
<term>Pregnancy (blood)</term>
<term>Pregnancy (psychology)</term>
<term>Prenatal Care</term>
<term>Stress, Psychological (blood)</term>
<term>Stress, Psychological (metabolism)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides gras omega-3 (usage thérapeutique)</term>
<term>Adulte</term>
<term>Afro-Américains (psychologie)</term>
<term>Compléments alimentaires</term>
<term>Femelle</term>
<term>Grossesse (psychologie)</term>
<term>Grossesse (sang)</term>
<term>Humains</term>
<term>Hydrocortisone (sang)</term>
<term>Jeune adulte</term>
<term>Prise en charge prénatale</term>
<term>Stress psychologique (métabolisme)</term>
<term>Stress psychologique (sang)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Hydrocortisone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fatty Acids, Omega-3</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Pregnancy</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Stress psychologique</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Afro-Américains</term>
<term>Grossesse</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>African Americans</term>
<term>Pregnancy</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Grossesse</term>
<term>Hydrocortisone</term>
<term>Stress psychologique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acides gras omega-3</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Dietary Supplements</term>
<term>Female</term>
<term>Humans</term>
<term>Prenatal Care</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Compléments alimentaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Prise en charge prénatale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To test the association between docosahexaenoic acid (DHA) supplementation and perceived stress and cortisol response to a stressor during pregnancy in a sample of African American women living in low-income environments.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25415158</PMID>
<DateCreated><Year>2014</Year>
<Month>11</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>01</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-233X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>124</Volume>
<Issue>6</Issue>
<PubDate><Year>2014</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Obstetrics and gynecology</Title>
<ISOAbbreviation>Obstet Gynecol</ISOAbbreviation>
</Journal>
<ArticleTitle>Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial.</ArticleTitle>
<Pagination><MedlinePgn>1080-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/AOG.0000000000000559</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test the association between docosahexaenoic acid (DHA) supplementation and perceived stress and cortisol response to a stressor during pregnancy in a sample of African American women living in low-income environments.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-four African American women were enrolled at 16-21 weeks of gestation. Power calculations were computed using published standard deviations for the Perceived Stress Scale and the Trier Social Stress Test. Participants were randomized to either 450 mg per day of DHA (n=43) or placebo (n=21). At baseline and at 24 and 30 weeks of gestation, perceived stress was assessed by self-report. Cortisol response to a controlled stressor, the Trier Social Stress Test was measured from saliva samples collected upon arrival to the laboratory and after the completion of the Trier Social Stress Test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Women in the DHA supplementation group reported lower levels of perceived stress at 30 weeks of gestation, controlling for depression and negative life events (mean 27.4 compared with 29.5, F [3, 47] 5.06, P=.029, Cohen's d=0.65). Women in the DHA supplementation had lower cortisol output in response to arriving to the laboratory and a more modulated response to the stressor (F [1.78, 83.85] 6.24, P=.004, Cohen's d=0.76).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pregnant women living in urban low-income environments who received DHA reported reduced perceived stress and lower levels of stress hormones in the third trimester. Docosahexaenoic acid supplementation may be a method for attenuating the effects of maternal stress during late pregnancy and improving the uterine environment with regard to fetal exposure to glucocorticoids.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov, www.clinicaltrials.gov, NCT01158976.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keenan</LastName>
<ForeName>Kate</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois; and the Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hipwell</LastName>
<ForeName>Alison E</ForeName>
<Initials>AE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bortner</LastName>
<ForeName>Jenna</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hoffmann</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>McAloon</LastName>
<ForeName>Rose</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT01158976</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y"><Grant><GrantID>R21 HD058269</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1 TR000005</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1 TR000430</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1TR000430</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Obstet Gynecol</MedlineTA>
<NlmUniqueID>0401101</NlmUniqueID>
<ISSNLinking>0029-7844</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber>
<NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Psychosom Res. 2013 Oct;75(4):351-7</RefSource>
<PMID Version="1">24119942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurosci Biobehav Rev. 1997 Jan;21(1):1-10</RefSource>
<PMID Version="1">8994205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Psychophysiol. 2013 Oct;90(1):8-16</RefSource>
<PMID Version="1">23085387</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Natl Vital Stat Rep. 2013 Jun 28;62(1):1-69, 72</RefSource>
<PMID Version="1">24974591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2000 May 15;47(10):910-20</RefSource>
<PMID Version="1">10807964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):285-98</RefSource>
<PMID Version="1">11750784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Psychobiol. 2002 Sep;41(2):178-85</RefSource>
<PMID Version="1">12209659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1078-85</RefSource>
<PMID Version="1">12218429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Psychobiol. 2002 Dec;41(4):373-87</RefSource>
<PMID Version="1">12430161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2003 Jan;111(1):e39-44</RefSource>
<PMID Version="1">12509593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Med Today. 1995 Dec;1(9):418-23</RefSource>
<PMID Version="1">9415190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ethn Dis. 2005 Winter;15(1):17-24</RefSource>
<PMID Version="1">15720045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2005 Mar;46(3):516-25</RefSource>
<PMID Version="1">15604519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychoneuroendocrinology. 2005 Oct;30(9):846-56</RefSource>
<PMID Version="1">15961250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychol Bull. 2005 Sep;131(5):662-83</RefSource>
<PMID Version="1">16187853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutr Neurosci. 2005 Aug;8(4):265-7</RefSource>
<PMID Version="1">16491653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2006 Apr;91(4):1329-35</RefSource>
<PMID Version="1">16434458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Feb 17;369(9561):578-85</RefSource>
<PMID Version="1">17307104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Peptides. 2007 Jun;28(6):1155-61</RefSource>
<PMID Version="1">17537545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Sci. 2007 Jul;10(4):464-80</RefSource>
<PMID Version="1">17552936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Adolesc Health. 2007 Jul;41(1):3-13</RefSource>
<PMID Version="1">17577528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Child Dev. 2010 Jan-Feb;81(1):131-48</RefSource>
<PMID Version="1">20331658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychiatr Clin North Am. 2010 Jun;33(2):441-63</RefSource>
<PMID Version="1">20385346</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Oct 20;304(15):1675-83</RefSource>
<PMID Version="1">20959577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prostaglandins Leukot Essent Fatty Acids. 2011 Jan-Feb;84(1-2):63-70</RefSource>
<PMID Version="1">20888744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2011 Dec;94(6):1592-9</RefSource>
<PMID Version="1">22071708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Environ Toxicol Pharmacol. 2012 Jan;33(1):26-38</RefSource>
<PMID Version="1">22056564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Obstet Gynecol Scand. 2007 Oct;86(10):1181-92</RefSource>
<PMID Version="1">17851798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutr Res. 2012 Apr;32(4):241-50</RefSource>
<PMID Version="1">22575036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2012 Aug 16;217:46-55</RefSource>
<PMID Version="1">22579981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2013 Aug;90:24-31</RefSource>
<PMID Version="1">23746605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Pregnancy Childbirth. 2013;13:129</RefSource>
<PMID Version="1">23759062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2013 Aug;98(2):396-402</RefSource>
<PMID Version="1">23783297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dev Psychobiol. 2013 Nov;55(7):707-18</RefSource>
<PMID Version="1">22778036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2003 May;160(5):996-8</RefSource>
<PMID Version="1">12727707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Metab. 2003 Jun;29(3):289-95</RefSource>
<PMID Version="1">12909818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Behav Med. 2004 Feb;27(1):63-76</RefSource>
<PMID Version="1">15065476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Health Soc Behav. 1983 Dec;24(4):385-96</RefSource>
<PMID Version="1">6668417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Psychiatry. 1987 Jun;150:782-6</RefSource>
<PMID Version="1">3651732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychobiology. 1993;28(1-2):76-81</RefSource>
<PMID Version="1">8255414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neuroendocrinol. 1994 Jun;6(3):341-5</RefSource>
<PMID Version="1">7920600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2013 Dec 15;210(2):575-83</RefSource>
<PMID Version="1">23876281</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">African Americans</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011295" MajorTopicYN="N">Prenatal Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS630447</OtherID>
<OtherID Source="NLM">PMC4241554</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>1</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25415158</ArticleId>
<ArticleId IdType="doi">10.1097/AOG.0000000000000559</ArticleId>
<ArticleId IdType="pii">00006250-201412000-00004</ArticleId>
<ArticleId IdType="pmc">PMC4241554</ArticleId>
<ArticleId IdType="mid">NIHMS630447</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
</region>
</list>
<tree><noCountry><name sortKey="Bortner, Jenna" sort="Bortner, Jenna" uniqKey="Bortner J" first="Jenna" last="Bortner">Jenna Bortner</name>
<name sortKey="Hipwell, Alison E" sort="Hipwell, Alison E" uniqKey="Hipwell A" first="Alison E" last="Hipwell">Alison E. Hipwell</name>
<name sortKey="Hoffmann, Amy" sort="Hoffmann, Amy" uniqKey="Hoffmann A" first="Amy" last="Hoffmann">Amy Hoffmann</name>
<name sortKey="Mcaloon, Rose" sort="Mcaloon, Rose" uniqKey="Mcaloon R" first="Rose" last="Mcaloon">Rose Mcaloon</name>
</noCountry>
<country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Keenan, Kate" sort="Keenan, Kate" uniqKey="Keenan K" first="Kate" last="Keenan">Kate Keenan</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003B52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amérique |area= PittsburghV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:25415158 |texte= Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25415158" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a PittsburghV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |